SEC ownership of Kezar Life Sciences, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001645666.

Comparable stake leader

Equal Talent Investments Ltd

Disclosed value leader

BML Capital Management, LLC

Comparable rows

45/50

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
45 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Equal Talent Investments Ltd
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001645666
Issuer location
South San Francisco, CA

Ownership snapshot

Top shareholders of Kezar Life Sciences, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Equal Talent Investments Ltd
Disclosed value leader
BML Capital Management, LLC
Comparable rows
45/50
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 8.7% 5 rows are not safely comparable across share classes. 13D/G row: Equal Talent Investments Ltd Showing 1-8 of 50 holder rows.

Quick read

Equal Talent Investments Ltd leads the comparable SEC ownership view at 8.7%.

45 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Equal Talent Investments Ltd's linked filing trail.
Comparable ownership Top 5
Equal Talent Investments Ltd 8.7%
Stonepine Capital Management, LLC 2.1%
BML Capital Management, LLC 9.7%
SUVRETTA CAPITAL MANAGEMENT, LLC 9.6%
TANG CAPITAL MANAGEMENT LLC 8.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Equal Talent Investments Ltd
13D/G
Equal Talent Investments Limited
8.7%
$487,037
616,502 shares
$0 28 Feb 2025
Stonepine Capital Management, LLC
13D/G
2.1%
$968,310
156,179 shares
-$1,370,578 31 Dec 2025
BML Capital Management, LLC
13F
Company
13F
9.7%
$5,348,240
720,787 shares
31 Mar 2026
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
9.6%
$5,318,352
716,759 shares
31 Mar 2026
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
8.9%
$4,929,210
664,314 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
3.9%
$2,155,725
290,529 shares
31 Mar 2026
Rangeley Capital, LLC
13F
Company
13F
3.3%
$1,803,602
243,073 shares
31 Mar 2026
Affinity Asset Advisors, LLC
13F
Company
13F
3.1%
$1,699,744
229,076 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$3,531.

Buys
$0
Insiders: 0
Sells
$3,531
Insiders: 2
Net
-$3,531
Shares: -825
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 825
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 825 $0 $3,531 -$3,531

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-17 of 17 reporting-owner rows connected to Kezar Life Sciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
17
Largest Forms 3/4/5 holder
Morningside Venture Investments Ltd
Net 12M change
-$3,531
Latest report
11 May 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Morningside Venture Investments Ltd 10%+ Owner $1,753,194 Mixed 15 Aug 2023
John Franklin Fowler Director $0 Mixed 11 May 2026
Franklin M. Berger Director $0 Mixed 11 May 2026
Michael Kauffman Director $0 Mixed 11 May 2026
Mark C. Schiller Chief Operating Officer $0 -$2,401 -100% Mixed 11 May 2026
Christopher J. Kirk CEO, Director $0 Mixed 11 May 2026
Marc Belsky Chief Financial Officer $0 Mixed 11 May 2026
Pichi Luo Chiang SVP, Corporate Controller $0 -$1,130 -100% Mixed 11 May 2026
Jean-Pierre Sommadossi Director Mixed 28 Jun 2021
Graham K. Cooper Director Mixed 11 May 2026
Elizabeth Garner Director Mixed 11 May 2026
Zung Phuong To Chief Development Officer Mixed 01 Jul 2025
Noreen Henig Chief Medical Officer Mixed 24 Jul 2023
Courtney Wallace Director Mixed 11 May 2026
Jason Dinges Director Mixed 28 Jun 2021
Nicholas Michael Mordwinkin Chief Business Officer Mixed 07 Jan 2024
Micki Klearman Director Mixed 11 May 2026

Recent insider transactions for Kezar Life Sciences, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Courtney Wallace KZR Stock Option (right to buy) Disposed to Issuer -100% -16,300 0 11 May 2026 Direct
Mark C. Schiller KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -2,739 0 11 May 2026 Direct
Mark C. Schiller KZR Employee Stock Option (right to buy) Disposed to Issuer -100% -114,745 0 11 May 2026 Direct
Micki Klearman KZR Stock Option (right to buy) Disposed to Issuer -100% -16,300 0 11 May 2026 Direct
Christopher J. Kirk KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -43,134 0 11 May 2026 Direct
Christopher J. Kirk KZR Employee Stock Option (right to buy) Disposed to Issuer -100% -328,997 0 11 May 2026 Direct
Michael Kauffman KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -6,369 0 11 May 2026 Direct
Michael Kauffman KZR Stock Option (right to buy) Disposed to Issuer -100% -12,378 0 11 May 2026 Direct
Graham K. Cooper KZR Stock Option (right to buy) Disposed to Issuer -100% -15,731 0 11 May 2026 Direct
Elizabeth Garner KZR Stock Option (right to buy) Disposed to Issuer -100% -13,768 0 11 May 2026 Direct
Franklin M. Berger KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -89,069 0 11 May 2026 Direct
Franklin M. Berger KZR Stock Option (right to buy) Disposed to Issuer -100% -11,100 0 11 May 2026 Direct
John Franklin Fowler KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -3,846 0 11 May 2026 By Montebello Holdings LLC
John Franklin Fowler KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -375 0 11 May 2026 By Trust
John Franklin Fowler KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -39,390 0 11 May 2026 Direct
John Franklin Fowler KZR Stock Option (right to buy) Disposed to Issuer -100% -324,317 0 11 May 2026 Direct
Marc Belsky KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -200 0 11 May 2026 By Trust
Marc Belsky KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -1,538 0 11 May 2026 Direct
Marc Belsky KZR Employee Stock Option (right to buy) Disposed to Issuer -100% -154,287 0 11 May 2026 Direct
Pichi Luo Chiang KZR Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -2,711 0 11 May 2026 Direct
Pichi Luo Chiang KZR Employee Stock Option (right to buy) Disposed to Issuer -100% -72,147 0 11 May 2026 Direct
Pichi Luo Chiang KZR Common Stock Sale -8.87% $1,130 $4.28 -264 2,711 02 Jul 2025 Direct
Mark C. Schiller KZR Common Stock Sale -17% $2,401 $4.28 -561 2,739 02 Jul 2025 Direct
Zung Phoung To KZR Employee Stock Option (right to buy) Award 7,000 7,000 01 Jul 2025 Direct
Micki Klearman KZR Stock Option (right to buy) Award 5,000 5,000 18 Jun 2025 Direct
Michael Kauffman KZR Stock Option (right to buy) Award 5,000 5,000 18 Jun 2025 Direct
Courtney Wallace KZR Stock Option (right to buy) Award 5,000 5,000 18 Jun 2025 Direct
Elizabeth Garner KZR Stock Option (right to buy) Award 5,000 5,000 18 Jun 2025 Direct
Graham K. Cooper KZR Stock Option (right to buy) Award 5,000 5,000 18 Jun 2025 Direct
Franklin M. Berger KZR Stock Option (right to buy) Award 5,000 5,000 18 Jun 2025 Direct
John Franklin Fowler KZR Stock Option (right to buy) Award 5,000 5,000 18 Jun 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .